Conversely, other studies have found that CD36 expression in pancreatic cancer cells and tissues is significantly lower than in corresponding normal tissues, with low CD36 expression predicting larger tumor size and poorer survival prognosis. This evidence concerns the gene CD36 and familial pancreatic carcinoma.